![]() |
|
|



*
Division of Nutritional Pathology, Faculty of Veterinary Medicine, CH-3012 Berne, Switzerland and
Unité Mixte de Recherches sur le Veau et le Porc, Institut National de la Recherches Agronomique, F-35042 Rennes, France
4To whom correspondence should be addressed at Division of Nutritional Pathology, Faculty of Veterinary Medicine, University of Berne, Bremgartenstr. 109a, CH-3012 Berne, Switzerland. E-mail: blum{at}itz.unibe.ch
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: neonates colostrum intestine pancreas calves
| INTRODUCTION |
|---|
|
|
|---|
Based on these premises, we tested the hypothesis that feeding the colostrum of the first milking in very high amounts for 7 d stimulates GIT growth and digestive enzyme activities of the GIT and pancreas compared with feeding the first colostrum for 3 d in amounts mimicking usual husbandry conditions. In addition, we tested the hypothesis that feeding colostrum has specific and greater effects on indicators of GIT growth and on digestive enzyme activities of the intestine and pancreas than does feeding a formula (which contained very similar amounts of nutrients but only traces of bioactive substances, including growth factors and hormones like IGF-I and insulin).
| MATERIALS AND METHODS |
|---|
|
|
|---|
The experimental procedures followed the Swiss Law on Animal Protection and were approved by the Committee for the Permission of Animal Experiments of the Canton of Freiburg, Granges-Paccot, Switzerland.
Twenty-one male calves of dairy breeds (Simmental x Red Holstein,
Holstein Friesian, and Brown Swiss) were available. The number of
animals tested per group (n = 7) was chosen based
on previous experiments (Bühler et al. 1998
,
Le Huërou-Luron et al. 1992
). Because calves were
killed and the studies were very expensive and time consuming, the
number of experimental animals was kept as low as possible. All calves
were single born after a normal-length pregnancy (290 d) and normal
parturition. They were obtained immediately after birth, weighed and
kept on straw litter in single boxes for 7 d at the Research
Station of the Division of Nutritional Pathology (Posieux,
Switzerland).
The body weight (BW) was measured immediately after birth and on d 4
and 7 of life, i.e., shortly before being killed (on d 8 of life). The
health status was evaluated daily using a scoring system as described
by Kühne et al. (2000
).
Calves were divided into three groups (GrCmax, GrC13 and GrF13). To protect against infections, all calves received 20 mL immunoglobulins subcutaneously (Gammaserin, containing 100 g immunoglobulin G/L; Dr. E. Gräub AG, Berne, Switzerland) on average within the first 4.5 h after birth. From d 2 on, calves were fed twice daily chicken eggderived immunoglobulins (Globigen 88; Lohmann Animal Health, Cuxhaven, Germany) in the amounts of 5 g (d 2), 4 g (d 3), 3 g (d 4) and 1 g (d 6 and 7). The product contained high amounts of specific antibodies against rotavirus and pathogenic Escherichia coli type K 99 but no bovine IGF-I or insulin. In addition, all navels were disinfected at birth.
Details of the feeding plans are shown in Table 1
. The GrCmax calves were fed colostrum from the
first milking that was undiluted on d 13 and was progressively
diluted with 25, 50, 75 and 75% of an MR (100 g/L water),
respectively, on d 47. The GrC13 calves were
fed the colostrum from milkings 16 during the first 3 d and then
an MR (100 g/L water), up to d 7. The GrF13
calves were fed a milk-based formula during the first 3 d and
then an MR (100 g/L water) up to d 7.
|
The compositions of colostrum milkings, formulas and MR are shown in
Table 2
. The colostrum was obtained from cows of the Swiss Federal Research
Station for Animal Production (Posieux, Switzerland). Colostrum for
calves of GrCmax was from a pool of first milking
from
20 cows. Colostrum for calves of GrC13
was from cows milked twice daily and was separately stored at -20°C
to make pools of milkings 16. Before feeding, the colostrum was
warmed to 40°C and then immediately fed. For
GrF13, three formulas (for meals on d 1, 2 and
3) were produced in cooperation with UFA AG (Sursee, Switzerland) and
contained comparable amounts of nutrients as colostrum obtained on d 1
(milking 1), d 2 (milking 3) and d 3 (milking 5), respectively. The
formulas consisted of calcium caseinate (a gift from Emmi Milch AG,
Lucerne, Switzerland), lactalbumin (a gift from Emmi Milch AG), lactose
(UFA AG), milk fat in the form of commercially available dairy double
cream (Agricultural Institute of the Canton of Fribourg,
Grangeneuve/Posieux, Switzerland) and a vitamin and mineral premix
routinely used in veal calves (Provimi S.A., Cossonay-Gare,
Switzerland). The MR (UFA-200 Natura; without antibiotics) was
purchased from UFA AG and was prepared as a 100 g/L solution.
|
1 h as described here. Food and drug analyses.
Aliquots of 50 mL colostrum from milkings 16, of MR and of
formulas (fed on d 13) were lyophilized, and dry matter, crude
protein (by the Kjeldahl method), crude lipid (by Soxleth extraction)
and crude ashes (after combustion at 550°C) were determined using
standard procedures at the Swiss Federal Research Station for Animal
Production (Posieux, Switzerland). Contents of nitrogen-free
extracts and gross energy (based on energy equivalents of 36.6, 17.0
and 24.2 MJ/kg crude fat, nitrogen-free extracts and crude protein,
respectively) were calculated (Table 2)
. Contents of MR were provided
by the producer (UFA AG Sursee, Switzerland). Food IGF-I and
insulin concentrations were determined as previously described
(Hammon and Blum 1997b
). Moreover, the concentration of
IGF-I was measured in Globigen 88 (where it was below the detection
limit) and in Gammaserin, the subcutaneously injected immunoglobulin
preparation (which contained 288 µg IGF-I/L).
Histomorphometry of intestinal mucosa.
After killing, the intestine was divided into duodenum,
mid-jejunum, ileum and colon, as described by Bühler et al. (1998
). Then, a tissue sample of each section of
4
x 4 cm was removed, stuck onto a piece of cork (to inhibit
shrinking) and transferred into a phosphate-buffered
paraformaldehyde (40 g/L) solution. After 24 h, three 1-mm-thick
cross-sectional pieces were cut from each sample and embedded in a
paraffin block. Ten cuts, 34 µm thick, were made of each block,
thus resulting in 30 different samples per intestinal site and calf.
For the histomorphometric analyses, from each paraffin block ten 3-
4-µm-thick sections of different regions were taken, put onto Super
Frost slides and stained with hematoxylin and eosin. Morphometric
analyses were conducted with a Zeiss light microscope connected to a
video-based, computer-linked system, as described by
Bühler et al. (1998
). Quantitative measurements
were made in at least 30 lengthwise-cut and well-oriented
crypt-villus preparations for each intestinal sample. Villus
circumferences, areas, heights and crypt depths were evaluated. The
coefficient of variation for villus circumferences, areas, heights and
crypt depths could be reduced <20%, if at least 30 villi and crypts
in the small intestine or crypts in the colon were evaluated. Mean
repeatability (variation within calves) of the 30 villi and crypts
determined in duodenum, jejunum and ileum was 0.51, and in the colon,
the repeatability for the determination of the 30 crypt depths was
0.71. To evaluate the day-to-day repeatabilities of determinations in
the small intestine and colon, we measured the same five villi and/or
five crypts on 5 consecutive d. In the small intestine, the
repeatabilities for villi parameters were 0.98, and in the colon, the
repeatability for crypt depths was 0.99. Furthermore, we measured
circumferences, areas and the vertical and horizontal diameters of
Peyers patches in the ileum (data not shown), and mean repeatability
was 0.91. We also counted goblet cells per length unit in at least 30
villus-crypt systems in the ileum (data not shown), and in this
case, the repeatability was 0.96.
Cell proliferation of intestinal mucosa.
Cell proliferation was based on counting cells that incorporate
5-bromo-2'-deoxyuridine (BrdU; Boehringer-Mannheim, Mannheim,
Germany) into DNA (Matsuura and Suzuki 1997
). Calves
were administered 500 mg BrdU intravenously, dissolved in 20 mL of PBS,
at 60 min before killing. Slides of intestinal tissue sections were
stained with a mouse monoclonal anti-BrdU antibody (No. 1 170 376;
Boehringer-Mannheim). BrdU incorporation was visualized with
biotinylated goat anti-mouse immunoglobulins (Dako A/S, Zug,
Switzerland), streptABComplex/AP-kit (Dako A/S) and Fast Red TR/Naphtol
AS-MX (Sigma Chemical Co., St. Louis, MO).
Furthermore, the proliferation of epithelial intestinal cells was
evaluated based on counting cells that are positive for protein Ki-67.
This protein is expressed in G1, S and G2
phases of all proliferating cells but not in resting cells
(Scholzen and Gerdes 2000
). To detect the Ki-67 protein,
a monoclonal antibody against Ki-67 (MIB 1; Dianova GmbH, Hamburg,
Germany) was used. Ki-67 was visualized using biotinylated anti-MIB
immunoglobulins and, finally, the peroxidase visualization system.
Two thousand intestinal epithelial cells were counted at the different intestinal segments for every calf. BrdU- or Ki-67labeled intestinal epithelial cells were calculated relative to unlabeled epithelial cells as well as relative to length (µm) of the mucosal epithelial layer, thus resulting in ratios of mitotic cells per total cells and the number of mitotic epithelial cells per µm, respectively, and served as a mirror of the cell proliferation rate.
Total amounts of DNA, RNA and protein in intestine and pancreas.
The DNA and RNA were quantitatively isolated with DNAzol reagent (GIBCO
BRL, Basle, Switzerland) and TRIzol reagent (GIBCO BRL), respectively.
Homogenization of gut segment samples and pancreas was performed with a
Mini-Beadbeater-8 cell disrupter (Biospec Products, Bartlesville, OK)
for 3 min. DNA and RNA were extracted according to the instructions of
the suppliers, and the pellets were resuspended in water or
diethylpyrocarbonate water, respectively. DNA (which served as a
measure of cell number or cell density) and RNA were quantified by
fluorometry with PicoGreen and RiboGreen RNA Quantitation kits,
respectively (Molecular Probes, Leiden, the Netherlands). The RNA/DNA
ratio was calculated and served as a measure of protein synthetic
capacity. The protein concentration was determined using the Pierce
(Rockford, IL) BCA protein assay as previously described
(Bühler et al. 1998
). The protein/RNA ratio served
as a measure of translation activity.
Activities of digestive enzymes in intestinal mucosa and pancreas.
About 3 g of mucosa was scraped off with a microscope slide
in the middle of duodenum, jejunum, ileum and colon at sites where
samples were taken for histomorphometric measurements and were
deep-frozen in liquid nitrogen. Frozen intestinal mucosa of each
gut segment was homogenized in ice-cold water (200 g/L) and, for
peptidase activity analysis, centrifuged for 5 min at 1000 x g at 4°C. The activities of aminopeptidases A and N
(EC 3.4.11.7 and EC 3.4.11.2, respectively) were assayed with
L-glutamyl-p-nitroanilide and
L-leucyl-p-nitroanilide as substrates
(Maroux et al. 1972), and that of dipeptidyl peptidase
IV (EC 3.4.14.5) was assayed with
glycyl-L-prolyl-p-nitroanilide
(Nagatsu et al. 1976
). The resulting enzymatic units
(IU) were expressed as µmol of p-nitroanilide
released/min at 37°C. Lactase (EC 3.2.1.23) and maltase (EC 3.2.1.20)
activities were determined using lactose in the absence of
p-chloromercuribenzoate and maltose as substrates
(Dahlquist 1964
). One disaccharidase unit (IU)
corresponded to the release of 1 µmol of glucose/min at 37°C.
Samples of the pancreas (corpus pancreatis) were frozen in liquid
nitrogen and stored at -80°C until assayed. Before enzymatic
analysis, zymogens in tissue homogenates were activated by trypsin (EC
3.4.21.4) as previously described (Le Huërou-Luron et al. 1992
). Trypsin (EC 3.4.21.1) and chymotrypsin (EC 3.4.21.2)
activities were assayed with
N-
-benzoyl-L-arginine-p-nitroanilide
(L-BA-pNA, B3133; Sigma Chemical Co.) and
succinyl-L-alanyl-L-alanyl-L-prolyl-L-phenylalanine-p-nitroanilide
(Suc-Ala2-Pro-pNA, S7388; Sigma Chemical Co.) as
substrates, respectively (Lain
et al. 1993
). Lipase
(EC 3.1.1.3) activity was determined by titrimetry using tributyrate as
a substrate as reported by Le Huërou-Luron et al. (1992
). Elastase I (EC 3.4.21.36) and II (EC 3.4.21.71)
activities were assayed with
succinyl-L-alanyl-L-alanyl-L-alanine-p-nitroanilide
(Suc-Ala3-pNa, L1385; Bachem AG, Bubendorf, Switzerland)
and
succinyl-L-alanyl-L-alanyl-L-prolyl-L-leucine-p-nitroanilide
(Suc-Ala2-Pro-Leu-pNa, L1390; Bachem AG) as substrates,
respectively. Elastase II substrate is also hydrolyzed by both
chymotrypsin and, in particular, elastase I. Therefore, the proportion
of elastase II substrate hydrolyzed by these two enzymes was quantified
and subtracted to express the true elastase II activity in pancreatic
homogenates (Gestin et al. 1997
). The resulting
enzymatic activities were expressed as µmol of substrates
released/min (IU).
Statistical procedures.
BW, total 7-d intakes, histomorphometric and histoproliferation values, as well as enzyme activities and DNA, RNA and protein concentrations in tissues, were expressed as means ± SEM. Intestinal data are shown for individual segments of the small intestine and for the colon.
Variations in individual measurements of histomorphometric analyses of the intestine were calculated by the SAS program with the VARCOMP procedure. Repeatability of individual measurements and (technical) repeatabilities were calculated as the ratio of variation from individual calves or the variation from several measurements of the same sample and the sum of variation from individual calves and errors (individual repeatabilities) or the sum of variation from several measurement and errors (technical repeatabilities).
To test differences in feeding (GrCmax versus
GrC13 and GrC13 versus
GrF13), histomorphometric and histoproliferation values
and enzymatic activities were evaluated using the RANDOM and REPEATED
methods of the MIXED procedure with an interanimal random effect of
differences between animals and a correlation structure within animals
(SAS 1994
). Feeding and gut segments were used as fixed
effects within animals. P-values were derived from
t tests using estimates after the MIXED procedure and
were considered significant if P < 0.05. The
significance of differences in intake was evaluated by Students
t test.
Group differences of DNA, RNA and protein concentrations in tissues
were evaluated by means of Wilcoxons two-sample test (SAS 1994
) because these variables were not normally distributed.
| RESULTS |
|---|
|
|
|---|
BW was 47.1 ± 4.5, 45.7 ± 6.7 and 47.7 ± 5.7 kg immediately after birth and 48.1 ± 1.7, 44.6 ± 2.4 and 43.6 ± 2.5 kg at age 7 d in GrCmax, GrC13 and GrF13, respectively. There were no significant group differences, but GrCmax maintained its BW, in contrast to the other groups.
Feed refusals were seldom, and calves that did not completely drink their feed were fed with an esophageal tube. The total 7-d intakes of groups GrCmax, GrC13 and GrF13 of dry matter (110 ± 6, 79 ± 2 and 68 ± 2 g · kg body-1 · wk-1, respectively), gross energy (2.6 ± 0.2, 1.7 ± 0.1 and 1.4 ± 0.1 MJ · kg body-1 · wk-1, respectively), crude protein (54 ± 3, 24 ± 0.7 and 22 ± 0.7 g · kg body-1 · wk-1, respectively) and crude fat (28 ± 2, 20 ± 0.1 and 17 ± 0.6 g · kg body-1 · wk-1, respectively) were always much higher (P < 0.05) in the GrCmax group than in the GrC13 group. The total 7-d intakes of nitrogen-free extracts (15 ± 0.7, 22 ± 1.7 and 18 ± 0.5 g · kg body-1 · wk-1for GrCmax, GrC13 and GrF13, respectively) were lower (P < 0.05) in the GrCmax group than in the GrC13 group. The 7-d intakes in GrC13 and GrF13 were similar, as planned.
Calves were healthy, and there were no obvious differences on the various health scores. However, loose feces were apparent in six GrCmax calves (lasting for 1 d in one calf, for 2 d in three calves and for 3 d in two calves), two GrC13 calves (lasting in one calf for 1 d and in one calf for 2 d) and in GrF13 calves (lasting for 2 d in all 7 calves), but fecal scores were very similar among the groups.
Villus circumferences, areas and heights and crypt depths in the small intestine and crypt depths in the colon.
Villus circumferences, areas and heights in the duodenum were greater
(P < 0.01) in GrCmax than in
GrC13 calves (Table 3
). Duodenal villus height/crypt depth ratios were also higher
(P < 0.01) in GrCmax than in
GrC13 calves.
|
Proliferation of small intestinal epithelial cells.
Intestinal cells labeled with BrdU and Ki-67 were almost exclusively found in the crypt regions of the intestinal mucosa. The numbers of BrdU- and Ki-67labeled cells per µm and per total cells in the small intestine were positively correlated (r = 0.5 and r = 0.56, respectively; P < 0.001).
The number of BrdU-labeled cells in the duodenum was lower
(P < 0.05) in GrCmax than in
GrC13 calves (Table 4
). Similar tendencies (P < 0.1) were observed in the
ileum. In addition, the number of duodenal Ki-67labeled cells was
lower (P < 0.05) in GrCmax than
in GrC13 calves.
|
Concentrations of DNA, RNA and protein in the intestine and pancreas.
Concentrations of DNA and RNA of the three groups in the small intestine (4.9 ± 0.6 and 16 ± 0.8 mg/g wet tissue, respectively) were not affected by differences in feeding. In the colon, the DNA concentration of the three groups was 0.6 ± 0.1 mg/g wet tissue and tended to be lower (P < 0.1) in GrCmax than in GrC13 calves (0.4 ± 0.08 and 0.9 ± 0.3 mg/g wet tissue, respectively). In the colon, the RNA concentration of the three groups was 11 ± 0.8 mg/g wet tissue and did not differ among groups. The protein concentration of the three groups in the small intestine and the colon was 94 ± 1.2 and 80 ± 3.7 mg/g wet tissue, respectively. The protein concentration was higher in GrCmax than in GrC13 calves in the jejunum (94.4 ± 1.9 and 86.9 ± 2.7 mg/g wet tissue, respectively; P < 0.05). In addition, the protein concentration in ileum tended to be lower (P < 0.1) in GrC13 than in GrCmax and GrF13 calves (91.7 ± 2.5, 98.0 ± 2.3, and 97.5 ± 2.4 mg/g wet tissue, respectively).
In the pancreas, RNA concentrations of the three groups (21 ± 1.1 mg/g wet tissue) did not differ among groups. DNA concentration of the three groups was 0.9 ± 0.2 mg/g wet tissue and tended to be lower (P < 0.1) in GrCmax than in GrC13 calves (0.5 ± 0.07 and 0.8 ± 0.2 mg/g wet tissue, respectively). Protein concentration of the three groups was 137 ± 3.4 mg/g wet tissue and tended to be higher (P < 0.1) in GrCmax than in GrC13 calves (144 ± 3.8 and 134 ± 5.7 mg/g wet tissue, respectively). There were no significant differences of RNA, DNA and protein concentrations between the GrF13 and GrC13 groups.
Jejunal and pancreatic enzyme activities.
In the jejunum, activities among the three groups of dipeptidyl peptidase, amino peptidase N, amino peptidase A, lactase and maltase were 223 ± 33, 383 ± 63, 80 ± 25, 7.9 ± 1.4 and 0.38 ± 0.04 IU/g mucosa, respectively. Dipeptidyl peptidase IV and maltase activities tended to be lower and higher (P < 0.1), respectively, in GrF13 than in GrC13 calves (dipeptidyl peptidase IV: 150 ± 18 and 232 ± 50 IU/g mucosa; maltase: 0.49 ± 0.1 and 0.33 ± 0.04 IU/g mucosa, respectively). There were no significant differences of intestinal enzyme activities between GrCmax and GrC13 calves.
In the pancreas, activities of the three groups of trypsin, chymotrypsin, lipase, elastase I and elastase II were 22 ± 3, 494 ± 73, 1061 ± 124, 11 ± 1 and 747 ± 133 IU/g pancreas. Pancreatic activity of lipase was higher (P < 0.05) and activities of trypsin and elastase II tended to be higher (P < 0.1) in GrCmax than in GrC13 calves (lipase: 1481 ± 110 and 945 ± 171 IU/g pancreas; trypsin: 28 ± 2 and 20 ± 4 IU/g pancreas; elastase II: 958 ± 118 and 626 ± 144 IU/g pancreas, respectively). There were no significant differences in pancreatic activities between GrC13 and GrF13 calves.
| DISCUSSION |
|---|
|
|
|---|
A decrease in dry matter, gross energy, crude protein, crude fat, crude
ashes, IGF-I and insulin concentrations and an increase in
nitrogen-free extracts (mainly of lactose) in the colostrum from
milkings 16 in the diets fed to the calves in this study were typical
(Campana and Baumrucker 1995
, Blum and Hammon 2000b
).
With feeding the formula, the experiment, which was designed to study
effects on the GIT and pancreas, was conducted under conditions not yet
performed in neonatal calves. Thus, the formula contained only trace
amounts of hormones (IGF-I, insulin), enzymes (e.g.,
-glutamyltransferase, alkaline phosphatase and alanine transferase;
J. W. Blum and H. M. Hammon, unpublished observations) and
other bioactive substances (e.g., lactoferrin; not shown) that are
otherwise present in high amounts in colostrum. However, the formula
contained comparable amounts of dry matter, gross energy, crude
protein, nitrogen-free extracts, crude fat and crude ashes as
colostrum of first 3 d of lactation and fed to
GrC13 calves. Because the colostrum and formula
were similarly composed with respect to nutrients and because the MR (d
47) was fed to groups GrC13 and
GrF13 in the same amounts, intakes of dry
matter, gross energy, crude protein and crude fat during the 1st wk of
life in these two groups were comparable. However, because the
GrC13 and GrF13 calves
on d 47 were fed the same MR, prolonged effects of differences in the
feeding of non-nutrient components during the first 3 d of
life could be studied when they were killed (on d 8).
The GrCmax calves ingested much greater amounts
of dry matter, gross energy, crude protein and crude fat but lower
amounts of nitrogen-free extracts than the
GrC13 calves. Calves of GrCmax were
probably fed maximally tolerable amounts of (first-milked) colostrum.
This allowed us to study effects of an excessive feeding intensity and
of non-nutrient components on the GIT and on the pancreas, thus
extending our previous investigations (Kühne et al. 2000
).
Effects on health status, growth performance and metabolic and
endocrine traits in GrCmax,
Gr13 and GrF13 calves
have been previously described (Rauprich et al. 2000a and 2000b
). In short, calves were generally healthy, and there were
no significant group differences in clinical traits. Loose feces
indicated mild disturbances of GIT function, which were transient but
could have caused reduced absorptive capacities in
GrF13 compared with
GrC13 calves (Rauprich et al. 2000a
).
Effects of maximizing compared with conventional colostrum intake.
Growth of the intestine in the first postnatal days follows an
inherent pattern determined by endogenous factors, but exogenous
factors, including nutrition, play roles as well. The postnatal
development of the GIT is well known to be greatly influenced by
colostrum intake (Bühler et al. 1998
, Odle et al. 1996
, Reinhart et al. 1992
,
Widdowson et al. 1976
, Xu 1996
). Based on
histomorphometric analyses, our study demonstrates that excessive
intake of first colostrum in GrCmax compared with
GrC13 calves especially stimulates the
development of the duodenal villus size during the first 8 d of
life. Villi of more distal segments of the small intestine were not
significantly influenced by differences in colostrum feeding intensity.
That the duodenum was more influenced by effects of colostrum intake
than were more distal parts of the small intestine also occurred in a
previous study (Bühler et al. 1998
). Nutrient and
non-nutrient components were likely to be present in greater
amounts in proximal than in distal parts of the intestine. Hence, their
effects were expectedly greater in the duodenum than in the jejunum and
ileum, i.e., they may have particularly stimulated duodenal growth.
However, the greater absorptive surface in GrCmax
than in GrC13 calves was not reflected by an
enhanced xylose absorption on d 5 of life (Rauprich et al. 2000b
), indicating that absorptive capacity could not be
further enhanced by maximizing and prolonging colostrum intake.
That intestinal cells labeled with BrdU and Ki-67 were almost
exclusively found in the crypt regions of the intestinal mucosa was not
surprising because new mucosal epithelial cells arise through mitosis
of stem cells and migrate up along the epithelial surface to the tip of
villi (Johnson 1988
). Most surprisingly, both BrdU and
Ki-67 labeling in the duodenum indicated smaller proliferation rates of
the mucosa of GrCmax compared with
GrC13 calves. Thus, although maximizing
colostrum feeding enhanced small intestinal villus size, it reduced
mucosal cell proliferation on d 8. However, because there were no
significant effects on DNA concentrations per gram of tissue in GIT
(and pancreas), cell density was not influenced. These results strongly
suggest that maximizing colostrum intake decreased apoptosis of the
mucosal epithelial cells. Reduction in apoptosis via colostrum intake
in high amounts may be a possibility (Playford et al. 2000
) and possibly was mediated by growth factors such as
IGF-I (Mylonas et al. 2000
), which is present in
high amounts in bovine colostrum (Blum and Hammon 2000b
,
Campana and Baumrucker 1995
). Because expression of
IGF-I in the duodenum, jejunum and ileum was not influenced by
differences in feed intake, whereas expression of IGF-I in the
liver was enhanced in GrCmax calves and was
closely and positively correlated with plasma IGF-I concentrations
(Cordano et al. 2000
and unpublished observations),
circulating IGF-I may be of greater importance than IGF-I
synthesized in the GIT.
The protein content of jejunum and ileum was higher in
GrCmax than in GrC13
calves. The ingestion of colostrum in neonatal rats and dogs was
associated with significant increases in intestinal mucosal protein
contents (Berseth et al. 1983
, Schwarz and Heird 1994
). Higher protein concentrations in the intestine might
have been the consequence of greater incorporation into epithelial
cells of immunoglobulins after enhanced colostrum feeding, as
demonstrated in neonatal calves (Patureau-Mirand et al. 1990
) and pigs (Burrin et al. 1992
). On the
other hand, no change was observed in intestinal digestive enzyme
activities.
The trend (although not significant) to higher protein concentrations
in the pancreas of GrCmax than that of
GrC13 calves might, too, have been an effect of
greater protein synthesis in response to excessive colostrum intake, in
accordance with metabolic and endocrine data obtained from calves of
this study (Cordano et al. 2000
, Rauprich et al. 2000b
). Trypsin and lipase activities were higher in
GrCmax than in GrC13
calves. This might have been mainly the consequence of higher protein,
fat and energy intakes in GrCmax calves compared
with GrC13 calves. In neonatal pigs, dietary
composition changes pancreatic enzyme activities, especially of lipase
(Le Huërou-Luron and Guilloteau 1999
).
Effects of milk-based formula intake compared with colostrum.
Replacement of colostrum by a milk-based formula
(GrF13) with a similar nutrient content as
colostrum (GrC13) caused reduced jejunal villus
size and showed a trend toward greater jejunal crypt depths on d 8.
This indicated that villus growth was reduced by formula feeding during
the first 3 d but suggested that GrF13
calves up to d 8 had started with the compensation of epithelial cell
growth. We found more markedly reduced villus sizes in the small
intestine when an MR with lower nutrient content than our formula was
fed instead of colostrum (Bühler et al. 1998
).
Besides nutrients, biologically active factors in colostrum may be
important for intestinal growth. Thus, growth factors like IGF-I
are stable in the neonatal GIT (Playford et al. 2000
,
Shen and Xu 2000
) and may enhance growth of the GIT
(Baumrucker et al. 1994a
, Burrin et al. 1996
, Odle et al. 1996
). As shown for IGF-I
and insulin and as expected for other factors like lactoferrin, the
near absence of these biologically active factors in
GrF13 calves may have been in part responsible
for reduced jejunal villus sizes compared with
GrC13 calves. Because (in the ileum) there were
no significant group differences in the size (and of the proliferation
rate) of Peyers patches and the number of goblet cells (S. Bittrich,
H. M. Hammon and J. W. Blum, unpublished
observations), this indicates that nutritional effects were relatively
specific and, in these tissues, small. In the colon,
surprisingly the crypt size was the greatest in
GrF13, suggesting that the proliferation of
epithelial cells in this part of the intestine was enhanced. The cause
or causes for this effect are not obvious.
The absence of significant nutritional effects on total DNA content in
the GIT and pancreas in GrF13 compared with
GrC13 calves indicates that the cell density
was not affected. In neonatal pigs, total DNA concentration also did
not differ when lactose or mature milk was fed instead of colostrum
(Simmen et al. 1990
). Furthermore, oral IGF-I,
IGF-II or insulin had no effect on mucosal DNA concentration in newborn
pigs (Shulman 1990
, Xu et al. 1994
).
However, in studies with neonatal rats and dogs, the ingestion of
colostrum was associated with significant increases in mucosal DNA
concentrations (Berseth et al. 1983
, Schwarz and Heird 1994
).
The proliferation rate of epithelial cells in the duodenum (based on
BrdU labeling) was lower in GrF13 than
GrC13 calves. These data support previous
findings that colostrum intake stimulates intestinal epithelial cell
proliferation more than mature milk or MR in neonatal calves
(Baumrucker et al. 1994a
) and pigs (Odle et al. 1996
, Ulshen et al. 1991
). Studies with neonates
fed insulin or IGF-I analogues showed enhanced proliferation rates
of the intestinal mucosa of calves, pigs, rats and humans
(Baumrucker et al. 1994a
, Ménard et al. 1999, Staley et al. 1998
, Xu 1996
). Therefore, colostral factors (e.g., IGF-I and
insulin) rather than nutrients may have been responsible for enhanced
stimulation of cell proliferation in the duodenal mucosa of
GrC13 compared with
GrF13 calves. Furthermore, systemic IGF-I
may have had an additional influence on gut growth, as seen in rats
(Read et al. 1992
). In addition to IGF-I, milk
contains many other factors (hormones, growth factors, gut regulatory
peptides, etc.) that could also be good candidates to stimulate small
intestinal growth. Surprisingly, the proliferation rate in the jejunum
(based on Ki-67 labeling) in GrF13 was higher
than that in GrC13 calves. Causes for this
deviating effect are not obvious.
Our study failed to show reduced intestinal and pancreatic protein
concentrations in GrF13 compared with
GrC13 calves. This was in contrast to
Burrin et al. (1995
), who found enhanced stimulation of
protein synthesis in jejunum, but not in pancreas, in colostrum-fed
compared with formula-fed neonatal pigs, an effect that appeared to
be mediated by non-nutritional factors rather than nutrients.
Again, one explanation for the failure to show an effect in our calves
might have been the relatively long time between formula feeding (up to
d 3 of life) and tissue sampling (on d 8 of life). Differences between
GrF13 and GrC13 calves
in intestinal enzyme activities may have reflected specific regulation
of enzyme synthesis, possibly caused by differences in the amount of
ingested bioactive substances, but they were unimpressive.
Although differences in villus size between
GrF13 and GrC13 calves
on d 8 of life were small, they were expectedly more marked on d 5 and
likely affected absorptive surface and explained differences in
nutrient absorptive capacity at this stage. In accordance, we have
found a smaller xylose absorption rate in GrF13
than GrC13 calves on d 5 of life
(Rauprich et al. 2000a
). Furthermore, plasma
concentrations of protein, triglycerides and insulin were lower and
that of cortisol was higher in GrF13 than in
GrC13 calves (Rauprich et al. 2000a
). This expressed a reduced nutritional status, possibly
as a consequence of decreased nutrient digestibilities and absorption
rates in GrF13 than in
GrC13 calves, even though nutrient intakes did
not differ.
In this study, maximization of colostrum intake enhanced duodenal villus size but reduced epithelial cell proliferation, suggesting that high and prolonged intake of colostrum may enhance the survival of intestinal epithelial cells and reduce mucosal epithelial cell turnover. The effects of high and prolonged colostrum intake on villus size and epithelial (crypt) cell proliferation were most marked in duodenum, i.e., at a site at which only partially digested components and likely still biologically active components of the chyme are present. Feeding only colostrum for 3 d seems to result in stimulation of small intestinal cell proliferation. Investigations into the mechanisms of regulation of apoptotic processes must be developed to clarify the role of colostrum intake on mucosal programmed cell death.
Feeding a formula containing only trace amounts of growth factors (e.g., IGF-I) and hormones (e.g., insulin) but similar amounts of nutrients as colostrum caused reduced villus size in jejunum and decreased crypt cell proliferation in the duodenum and ileum, indicating that colostral bioactive components (e.g., growth factors and hormones) had effects beyond those of nutrients and increased proliferation in selected parts of the small intestine.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
rmedizinischen Gesellschaft, April 34, 2000, University of Munich, Munich, Germany [Blättler, U., Hammon, H. M., Le Huërou-Luron, I., Guilloteau, P. & Blum, J. W. (2000) Effects of different colostrum intake on morphology, cell proliferation and enzyme activities in the gut of neonatal calves].
2 Submitted as the thesis of U. Blüttler to the Faculty of Veterinary Medicine, University of Berne, Berne,
Switzerland, February 2001. ![]()
3 Supported by the Swiss National Science Foundation (Grant 35 3200-05102.97/1). ![]()
5 Abbreviations used: BrdU, 5-bromo-2'-deoxyuridine; BW, body weight; GIT, gastrointestinal tract; GrCmax, fed colostrum of first milking that was fed undiluted on d 13 and diluted with 25, 50, 75 and 75 parts of a milk replacer on d 47, respectively; GrC13, fed colostrum of milkings 16 during the first 3 d and then a milk replacer up to d 7; GrF13, fed a milk-based formula (containing only traces of growth factors and hormones such as insulin-like growth factor-I and insulin) during the first 3 d and then a milk replacer up to d 7; IGF, insulin-like growth factor; MR, milk replacer. ![]()
Manuscript received September 22, 2000. Initial review completed October 12, 2000. Revision accepted December 15, 2000.
| REFERENCES |
|---|
|
|
|---|
1. Baumrucker C. R., Hadsell D. L., Blum J. W. Effects of dietary insulin-like growth factor I on growth and insulin-like growth factor receptors in neonatal calf intestine. J. Anim. Sci. 1994a;72:428-433[Abstract]
2. Baumrucker C. R., Green M. H., Blum J. W. Effects of dietary rhIGF-I in neonatal calves on the appearance of glucose, insulin, d-xylose, globulins and gamma-glutamyl transferase in blood. Domest. Anim. Endocrinol. 1994b;11:393-403[Medline]
3.
Berseth C. L., Lichtenberger L. M., Morries F. H. Comparison of the gastrointestinal growth-promoting effects of rat colostrum and mature milk in newborn rats in vivo. Am. J. Clin. Nutr. 1983;37:52-60
4. Blum J.W., Hammon H.M. Kolostrummehr als nur ein Immmunglobulinlieferant. Schweiz. Arch. Tierheilkde. 2000a;5:221-228
5. Blum J.W., Hammon H. M. Colostrum effects on the gastrointestinal tract, and on nutritional, endocrine and metabolic parameters in neonatal calves. Lifest. Prod. Sci. 2000b;66:1151-1159
6.
Bühler C., Hammon H., Rossi G. L., Blum J. W. Small intestinal morphology in eight-day-old calves fed colostrum for different duration or only milk replacer and treated with long-R3-insulin-like growth factor-I and growth hormone. J. Anim. Sci. 1998;76:758-765
7. Burrin D. G., Shulman R. J., Reeds P. J., Davis T. A., Gravitt K. R. Porcine colostrum and milk stimulate visceral organ and skeletal muscle synthesis in neonatal pigs. J. Nutr. 1992;122:1205-1213
8. Burrin D. G., Davis T. A., Ebner S., Schoknecht P. A., Fiorotto M. L., Reeds P. J., McAvoy S. Nutrient-independent and nutrient-dependent factors stimulate protein synthesis in colostrum-fed newborn pigs. Pediatr. Res. 1995;37:593-599[Medline]
9.
Burrin D. G., Wester T. J., Davis T. A., Amick S., Heath J. P. Orally administered IGF-I increases intestinal mucosal growth in formula-fed neonatal pigs. Am. J. Physiol. 1996;270:R1085-R1091
10. Campana W. M., Baumrucker C. R. Hormones and growth factors in bovine Milk. Jensen R. G. eds. Handbook of Milk Composition 1995:476-494 Academic Press San Diego, CA.
11. Cordano P., Hammon H.M., Morel C., Zurbriggen A., Blum J.W. mRNA of insulin-like growth factor quantification and presence of IGF binding proteins, and receptors for growth hormone, IGF-I and insulin, determined by reverse transcribed polymerase chain reaction, in the liver of growing and mature male cattle. Domest. Anim. Endocrinol. 2000;19:191-208[Medline]
12. Dahlquist A. Method for assay of intestinal disaccharidases. Anal. Biochem. 1964;7:18-25[Medline]
13. Gestin M., Le Huërou-Luron I., Peiniau J., Thioulouse E., Desbois C., Le Drean G., Feldman D., Aumaitre A., Guilloteau P. Method of measurement of pancreatic elastase II activity and postnatal development of proteases in human duodenal juice and bovine and porcine pancreatic tissue. Dig. Dis. Sci. 1997;42:1302-1311[Medline]
14. Grütter R., Blum J. W. Insulin and glucose in neonatal calves after peroral insulin and intravenous glucose administration. Repord. Nutr. Dev. 1991a;1:389-397
15. Grütter R., Blum J. W. Insulin-like growth factor I in neonatal calves fed colostrum or whole milk and injected with growth hormone. J. Anim. Physiol. Anim. Nutr. 1991b;66:231-239
16. Guilloteau P., Le Huërou-Luron I., Chayvialle J. A., Toullec R., Zabielski R., Blum J. W. Gut regulatory peptides in young cattle and sheep. J. Vet. Med 1997;A44:1-23
17. Hadorn U., Blum J. W. Effects of feeding colostrum, glucose or water on the first day of life on plasma immunoglobulin G concentration and gamma-glutamyltransferase activities in calves. J. Vet. Med 1997;A44:531-537
18.
Hadorn U., Hammon H., Bruckmeier R. M., Blum J. W. Delaying colostrum intake by one day has important effects on metabolic traits and on gastrointestinal and metabolic hormones in neonatal calves. J. Nutr. 1997;127:2011-2023
19.
Hammon H., Blum J. W. Prolonged colostrum feeding enhances xylose absorption in neonatal calves. J. Anim. Sci. 1997a;75:2915-2919
20.
Hammon H., Blum J. W. The somatotropic axis in neonatal calves can be modulated by nutrition, growth hormone, and long-R3-IGF-I. Am. J. Physiol. 1997b;273:E130-E138
21.
Hammon H., Blum J. W. Metabolic and endocrine traits of neonatal calves are influenced by feeding colostrum for different duration or only milk replacer. J. Nutr. 1998;128:624-632
22.
Johnson L. R. Regulation of gastrointestinal mucosal growth. Physiol. Rev. 1988;68:456-502
23.
Kühne S., Hammon H. M, Bruckmaier R. M., Blum J. W. Growth performance, metabolic and endocrine traits, and intestinal absorptive capacity in neonatal calves fed either colostrum or milk replacer at low and high intensities. J. Anim. Sci. 2000;78:609-620
24. Lainé J., Beattie M., Le Bel D. Simultaneous kinetic determination of lipase, chymotrypsin, trypsin, elastase and amylase on the same microtiter plate. Pancreas 1993;8:383-386[Medline]
25. Le Huërou-Luron I., Guilloteau P., Wicker-Planquart C., Chayvialle J.-A., Burton J., Mouats A., Toullec R., Puigserver A. Gastric and pancreatic enzyme activities and their relationship with some gut regulatory peptides during postnatal development and weaning in calves. J. Nutr. 1992;122:1434-1445
26. Le Huërou-Luron I., Guilloteau P. Effects of age and food on exocrine pancreatic function and some regulatory aspects. Pierzynowski S. G. Zabielski R. eds. Biology of the Pancreas in Growing Animals 1999:213-229 Elsevier Amsterdam.
27. Lee C. Y., Head H. H., Feinstein C. R., Hayen J., Simmen F. A. Endocrine changes and circulating insulin-like growth factors in newborn calves fed colostrum, milk or milk replacer. Asian. J. Anim. Sci. 1995;8:51-58
28. Maroux S., Louvard M., Baratti J. The aminopeptidases from hog intestinal brush border. Biochem. Biophys. Acta 1973;321:282-295[Medline]
29.
Matsuura S., Suzuki K. Immunohistochemical analysis of DNA synthesis during chronic stimulation with isoproterenol in mouse submandibular gland. J. Histochem. Cytochem. 1997;45:1137-1145
30.
Michanek P., Ventorp M., Westr
m B. Intestinal transmission of macromolecules in newborn dairy calves of different ages at first feedings. Res. Vet. Sci. 1989;46:375-379[Medline]
31. Mylonas P. G., Matsouka P. T., Papandoniou E. V., Vagianos C., Kalafarentzos F., Alexandrides T. K. Growth hormone and insulin-like growth factor-I protect intestinal cells from radiation-induced apoptosis. Mol. Cell. Endocrinol. 2000;160:115-122[Medline]
32. Nagatsu T., Hino M., Fuyamada H., Hayakawa T., Sakakibara S., Nakagawa Y., Takemoto T. New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase. Anal. Biochem. 1976;74:466-476[Medline]
33. Odle J., Zijlstra R. T., Donovan S. M. Intestinal effects of milkborne growth factors in neonates of agricultural importance. J. Anim. Sci. 1996;74:2509-2522[Abstract]
34. Patureau-Mirand P., Mosoni L., Levieux D., Attaix D., Bayle G., Bonnet Y. Effect of colostrum feeding on protein metabolism in the small intestine of newborn lambs. Biol. Neonate 1990;57:30-36[Medline]
35. Playford R. J., MacDonald C. E., Johnson W. S. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am. J. Clin. Nutr. 2000;72:4-14
36. Rauprich A.B.E., Hammon H. M., Blum J. W. Effects of feeding colostrum and formula with nutrient contents as colostrum on growth performance, health status, and metabolic and endocrine traits in neonatal calves. Biol. Neonate 2000a;78:53-64[Medline]
37.
Rauprich A.B.E., Hammon H. M., Blum J. W. Influence of feeding different amounts of first colostrum on metabolic, endocrine, and health status, and growth performance in neonatal calves. J. Anim. Sci. 2000b;78:896-908
38. Read L. C., Howarth G. S., Lemmey A. B., Steeb C., Trahair J., Tomas F. M., Ballard F. J. The gastrointestinal tract: a most sensitive target for IGF-I. Proc. Nutr. Soc. NZ 1992;17:136-142
39. Reinhart G. A., Simmen F. A., Mahan D. C., White M. E., Roehrig K. L. Intestinal development and fatty acid binding protein activity of newborn pigs fed colostrum or milk. Biol. Neonate 1992;62:155-163[Medline]
40. SAS Institute Introductory Comparison of the GLM and Mixed Procedure 1994 SAS Institute Inc Cary, NC.
41. Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 2000;182:311-322[Medline]
42.
Schwarz S. M., Heird W. C. Effects of feeding on the small intestinal mucosa of beagle pups during the first 5 d of life. Am. J. Clin. Nutr. 1994;60:879-886
43. Shen W. H., Xu R. J. Stability of insulin-like growth factor I in the gastrointestinal lumen in neonatal pigs. J. Pediatr. Gastroenterol. Nutr. 2000;30:299-304[Medline]
44. Shulman R. J. Oral insulin increases small intestinal mass and disaccaridase activity in the newborn miniature pig. Pediatr. Res. 1990;28:171-175[Medline]
45. Simmen F. A., Cera K. R., Mahan D. C. Stimulation by colostrum or mature milk of gastrointestinal tissue development in newborn pigs. J. Anim. Sci. 1990;68:3596-3603[Abstract]
46. Staley M. D., Gibson C. A., Herbein J. F., Grosvenor C. E., Baumrucker C. R. Rat milk and dietary long-R3-insulin-like growth factor I promote intestinal growth of newborn rat pups. Pediatr. Res. 1998;44:512-518[Medline]
47. Ulshen M. H., Lecce J. G., Stiles A. D., Lyn-Cook L. E. Effects of nursing on growth and development of small bowel mucosa in newborn piglets. Pediatr. Res. 1991;30:337-341[Medline]
48. Widdowson E. M., Colombo V. E., Artavanis C. A. Changes in the organs of pigs in response to feeding for the first 24 h after birth. Biol. Neonate 1976;28:272-281
49. Vacher P. Y., Bestetti G. E., Blum J. W. Insulin-like growth factor I absorption in the jejunum of neonatal calves. Biol. Neonate 1995;68:354-367[Medline]
50. Xu R.-J. Development of the newborn GI tract and its relation to colostrum/milk intake: a review. Reprod. Fertil. Dev. 1996;8:35-48[Medline]
51. Xu R.-J., Mellor D. J., Birtles M. J., Breier B. H., Gluckman P. D. Effects of oral IGF-I or IGF-II on digestive organ growth in newborn piglets. Biol. Neonate 1994;66:280-287[Medline]
This article has been cited by other articles:
![]() |
K. Rufibach, N. Stefanoni, V. Rey-Roethlisberger, P. Schneiter, M. G. Doherr, L. Tappy, and J. W. Blum Protein synthesis in jejunum and liver of neonatal calves fed vitamin A and lactoferrin. J Dairy Sci, August 1, 2006; 89(8): 3075 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schottstedt, C. Muri, C. Morel, C. Philipona, H. M. Hammon, and J. W. Blum Effects of Feeding Vitamin A and Lactoferrin on Epithelium of Lymphoid Tissues of Intestine of Neonatal Calves J Dairy Sci, March 1, 2005; 88(3): 1050 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Ontsouka, B. Korczak, H. M. Hammon, and J. W. Blum Real-Time PCR Quantification of Bovine Lactase mRNA: Localization in the Gastrointestinal Tract of Milk-Fed Calves J Dairy Sci, December 1, 2004; 87(12): 4230 - 4237. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bittrich, C. Philipona, H. M. Hammon, V. Rome, P. Guilloteau, and J. W. Blum Preterm as Compared with Full-Term Neonatal Calves Are Characterized by Morphological and Functional Immaturity of the Small Intestine J Dairy Sci, June 1, 2004; 87(6): 1786 - 1795. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Hammer, J. D. Quigley, L. Ribeiro, and H. D. Tyler Characterization of a Colostrum Replacer and a Colostrum Supplement Containing IgG Concentrate and Growth Factors J Dairy Sci, January 1, 2004; 87(1): 106 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Roffler, A. Fah, S. N. Sauter, H. M. Hammon, P. Gallmann, G. Brem, and J. W. Blum Intestinal Morphology, Epithelial Cell Proliferation, and Absorptive Capacity in Neonatal Calves Fed Milk-Born Insulin-Like Growth Factor-I or a Colostrum Extract J Dairy Sci, May 1, 2003; 86(5): 1797 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Jensen, J. Elnif, D. G. Burrin, and P. T. Sangild Development of Intestinal Immunoglobulin Absorption and Enzyme Activities in Neonatal Pigs Is Diet Dependent J. Nutr., December 1, 2001; 131(12): 3259 - 3265. [Abstract] [Full Text] [PDF] |
||||
| |||||